Your browser doesn't support javascript.
loading
Simultaneous care in oncology: Assessment of benefit in relation to symptoms, sex, and age in 753 patients.
Galiano, Antonella; Schiavon, Stefania; Nardi, Mariateresa; Guglieri, Irene; Pambuku, Ardi; Martino, Rosalba; Bolshinsky, Maital; Murgioni, Sabina; Intini, Rossana; Soldà, Caterina; Marino, Dario; Daniel, Francesca; De Toni, Chiara; Pittarello, Chiara; Chiusole, Benedetta; Prete, Alessandra Anna; Bimbatti, Davide; Nappo, Floriana; Caccese, Mario; Bergamo, Francesca; Brunello, Antonella; Lonardi, Sara; Zagonel, Vittorina.
Afiliación
  • Galiano A; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Schiavon S; Pain Therapy and Palliative Care Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Nardi M; Clinical Nutrition Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Guglieri I; Oncology Unit, "Villa Scassi" Hospital, Genua, Italy.
  • Pambuku A; Pain Therapy and Palliative Care Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Martino R; Hospital Psychology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Bolshinsky M; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Murgioni S; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Intini R; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Soldà C; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Marino D; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Daniel F; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • De Toni C; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Pittarello C; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Chiusole B; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Prete AA; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Bimbatti D; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Nappo F; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Caccese M; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Bergamo F; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Brunello A; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Lonardi S; Department of Oncology, Oncology Unit 3, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Zagonel V; Department of Oncology, Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Front Oncol ; 12: 989713, 2022.
Article en En | MEDLINE | ID: mdl-36313660
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Italia